Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Long-Term Deferred Tax (2023 - 2024)

Historic Long-Term Deferred Tax for Onconetix (ONCO) over the last 2 years, with Q4 2024 value amounting to $25114.0.

  • Onconetix's Long-Term Deferred Tax fell 9807.32% to $25114.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $25114.0, marking a year-over-year decrease of 9807.32%. This contributed to the annual value of $25114.0 for FY2024, which is 9807.32% down from last year.
  • Onconetix's Long-Term Deferred Tax amounted to $25114.0 in Q4 2024, which was down 9807.32% from $1.3 million recorded in Q4 2023.
  • Over the past 5 years, Onconetix's Long-Term Deferred Tax peaked at $1.3 million during Q4 2023, and registered a low of $25114.0 during Q4 2024.